TARS

NASDAQ HEALTHCARE

Tarsus Pharmaceuticals Inc

$78.23

-$1.72 (-2.15%)

Live quote

52w: $48.76 – $91.53

Loading chart…

P/E Ratio—

P/B Ratio10.12

EV/EBITDA—

Debt/Equity—

ROE-19.16%

ROIC—

Revenue Growth146.71%

Gross Margin—

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Own TARS? Track it here.

Create a free account to add TARS to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account